Reuters logo
BRIEF-Aldeyra Therapeutics Q2 loss per share $0.35
2017年8月8日 / 中午12点11分 / 3 个月前

BRIEF-Aldeyra Therapeutics Q2 loss per share $0.35

Aug 8 (Reuters) - Aldeyra Therapeutics Inc

* Aldeyra therapeutics announces second quarter 2017 financial results

* Q2 loss per share $0.35

* Q2 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S

* Aldeyra therapeutics inc - ‍ data from phase 2a clinical trial in dry eye disease expected to be announced in september 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below